A pilot study to examine the feasibility and effect on tumor necrosis factor (TNF) inhibition on HIV disease
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Etanercept (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 25 Oct 2016 Status changed from recruiting to completed.
- 28 Oct 2006 New trial record.